Strong evidence has demonstrated that aberrant STAT3 signaling promotes the initiation and progression of human cancers (including lung cancer) by either inhibiting apoptosis or inducing cell proliferation, angiogenesis, invasion, and metastasis (17). Here, STAT3 is linked to lung carcinoma.